|
ZFP91 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.323520E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.481000E-03 |
| Normal-vs-Stage2 |
1.267610E-01 |
| Normal-vs-Stage3 |
1.055310E-03 |
| Normal-vs-Stage4 |
6.118100E-03 |
| Stage1-vs-Stage2 |
6.383000E-01 |
| Stage1-vs-Stage3 |
2.388200E-01 |
| Stage1-vs-Stage4 |
4.886400E-01 |
| Stage2-vs-Stage3 |
2.185600E-01 |
| Stage2-vs-Stage4 |
3.665400E-01 |
| Stage3-vs-Stage4 |
8.527200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.136500E-03 |
| Normal-vs-AfricanAmerican |
3.844400E-01 |
| Normal-vs-Asian |
1.396330E-02 |
| Caucasian-vs-AfricanAmerican |
2.561400E-01 |
| Caucasian-vs-Asian |
9.282600E-01 |
| AfricanAmerican-vs-Asian |
2.791600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.222100E-04 |
| Normal-vs-Female |
6.362100E-03 |
| Male-vs-Female |
5.725500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.074300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.060500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.561200E-03 |
| Normal-vs-Age(81-100Yrs) |
2.213900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.923400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.971200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.131600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.539600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.620400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.072600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.683400E-01 |
| Classical-VS-Follicular |
6.572400E-02 |
| Classical-VS-Other |
5.154400E-02 |
| Classical-VS-Normal |
3.991700E-02 |
| Tall-VS-Follicular |
6.707600E-01 |
| Tall-VS-Other |
9.936500E-02 |
| Tall-VS-Normal |
2.659900E-02 |
| Follicular-VS-Other |
2.532200E-01 |
| Follicular-VS-Normal |
2.096300E-03 |
| Other-VS-Normal |
3.316100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.384300E-04 |
| Normal-vs-N1 |
3.316100E-03 |
| N0-vs-N1 |
5.397000E-01 |
|
|
